123 related articles for article (PubMed ID: 11291207)
1. Analyzing current practice patterns: lessons from Amgen's Project ChemoInsight.
Hayes NA
Oncol Nurs Forum; 2001 Mar; 28(2 Suppl):11-6. PubMed ID: 11291207
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy dose and dose intensity: analyzing data to guide therapeutic decisions.
Gillespie TW
Oncol Nurs Forum; 2001 Mar; 28(2 Suppl):5-10. PubMed ID: 11291209
[TBL] [Abstract][Full Text] [Related]
3. Nurses' guide to understanding and implementing the National Comprehensive Cancer Network guidelines for myeloid growth factors.
Wilson BJ; Gardner AE
Oncol Nurs Forum; 2007 Mar; 34(2):347-53. PubMed ID: 17573299
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices.
Lyman GH; Dale DC; Crawford J
J Clin Oncol; 2003 Dec; 21(24):4524-31. PubMed ID: 14673039
[TBL] [Abstract][Full Text] [Related]
5. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.
Shayne M; Crawford J; Dale DC; Culakova E; Lyman GH;
Breast Cancer Res Treat; 2006 Dec; 100(3):255-62. PubMed ID: 16705366
[TBL] [Abstract][Full Text] [Related]
6. Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia.
Donohue R
Oncol Nurs Forum; 2006 Nov; 33(2):347-52. PubMed ID: 16518450
[TBL] [Abstract][Full Text] [Related]
7. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
[TBL] [Abstract][Full Text] [Related]
8. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses.
Kearney N; Friese C
Eur J Oncol Nurs; 2008 Feb; 12(1):14-25. PubMed ID: 18291720
[TBL] [Abstract][Full Text] [Related]
9. The advanced practice nursing role in a high-risk breast cancer clinic.
Vogel WH
Oncol Nurs Forum; 2003; 30(1):115-22. PubMed ID: 12515989
[TBL] [Abstract][Full Text] [Related]
10. Neutropenia: state of the knowledge part I.
Nirenberg A; Bush AP; Davis A; Friese CR; Gillespie TW; Rice RD
Oncol Nurs Forum; 2006 Nov; 33(6):1193-201. PubMed ID: 17149402
[TBL] [Abstract][Full Text] [Related]
11. Impact of neutropenia on delivering planned chemotherapy for solid tumours.
Khan S; Dhadda A; Fyfe D; Sundar S
Eur J Cancer Care (Engl); 2008 Jan; 17(1):19-25. PubMed ID: 18181887
[TBL] [Abstract][Full Text] [Related]
12. Advocating for quality cancer care: making evidence-based practice a reality.
Mooney KH
Oncol Nurs Forum; 2001 Mar; 28(2 Suppl):17-21. PubMed ID: 11291208
[TBL] [Abstract][Full Text] [Related]
13. Neutropenia: state of the knowledge part II.
Nirenberg A; Parry Bush A; Davis A; Friese CR; Wicklin Gillespie T; Rice RD
Oncol Nurs Forum; 2006 Nov; 33(6):1202-8. PubMed ID: 17149403
[TBL] [Abstract][Full Text] [Related]
14. Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey.
Repetto L;
Crit Rev Oncol Hematol; 2009 Nov; 72(2):170-9. PubMed ID: 19406660
[TBL] [Abstract][Full Text] [Related]
15. A chemotherapy standard order form: preventing errors.
Opfer KB; Wirtz DM; Farley K
Oncol Nurs Forum; 1999; 26(1):123-8. PubMed ID: 9921575
[TBL] [Abstract][Full Text] [Related]
16. Neutropenia management with granulocyte colony-stimulating factors: from guidelines to nursing practice protocols.
Dolan S; Crombez P; Munoz M
Eur J Oncol Nurs; 2005; 9 Suppl 1():S14-23. PubMed ID: 16207534
[TBL] [Abstract][Full Text] [Related]
17. Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.
Kümmel S; Krocker J; Kohls A; Breitbach GP; Morack G; Budner M; Blohmer JU; Lichtenegger W; Elling D
Crit Rev Oncol Hematol; 2006 May; 58(2):166-75. PubMed ID: 16387512
[TBL] [Abstract][Full Text] [Related]
18. Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group.
Skarlos DV; Timotheadou E; Galani E; Samantas E; Grimani I; Lianos E; Aravantinos G; Xanthakis I; Pentheroudakis G; Pectasides D; Fountzilas G
Oncology; 2009; 77(2):107-12. PubMed ID: 19622901
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic therapy in patients receiving cancer chemotherapy.
Marek C
Oncol Nurs Forum; 2003; 30(2):259-71. PubMed ID: 12692660
[TBL] [Abstract][Full Text] [Related]
20. Metastatic breast cancer: understanding current management options.
McGinn K; Moore J
Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
